Adolescent depression is a prevalent and disabling condition resulting in emotional suffering and social and educational dysfunction. Care for adolescent depression is suboptimal and could be improved through the development and use of quality indicators (QIs). This article reports on the development of a care pathway and QIs for the primary and specialty care management of adolescent depression from case identification through symptom remission. It presents evidence from a review of adolescent clinical practice guidelines and research literature to support QIs at critical nodes in the pathway, and describes implications for practice based on existing evidence. Barriers to measure development are identified, including gaps in empirical evidence, and a research agenda is suggested.
Evidence for the Management of Adolescent Depression
FINANCIAL DISCLOSURE: Drs Lewandowski, Acri, Hoagwood, Olfson, Gardner, Scholle, Kelleher, and Horwitz and Ms Byron and Frank were supported in this work by funds from Agency for Healthcare Research and Quality grant U18HS020503; and Drs Clarke and Pincus have indicated they have no financial relationships relevant to this article to disclose.
- Views Icon Views
- Share Icon Share
- Search Site
R. Eric Lewandowski, Mary C. Acri, Kimberly E. Hoagwood, Mark Olfson, Greg Clarke, William Gardner, Sarah Hudson Scholle, Sepheen Byron, Kelly Kelleher, Harold A. Pincus, Samantha Frank, Sarah M. Horwitz; Evidence for the Management of Adolescent Depression. Pediatrics October 2013; 132 (4): e996–e1009. 10.1542/peds.2013-0600
Download citation file: